Have you been struggling with Ulcerative Colitis or IBD?

Join our clinical research study evaluating whether a new medication that blocks the TL1A protein can effectively treat moderate to severe ulcerative colitis.

Study Benefits

No Cost
Free Transportation via Uber
Compensation Provided

Quick 30-Second Eligibility Check

Answer a few simple questions to see if you qualify for the study.

Have you been diagnosed with ulcerative colitis and are actively experiencing symptoms?

Your information is secure and will only be used to determine study eligibility.

What Would Taking Part Mean for Me?

Taking part in this study may provide you with an opportunity to:

Have in-depth, long-term monitoring of your health. This includes access to specialist medical tests that would not be part of standard care outside of a clinical study.

Receive long-term nutrition and physical activity advice to support you in adopting healthier lifestyle choices.

Gain in-depth understanding of your condition.

Be a partner in this quest to help improve understanding of Ulcerative Colitis.

Potentially help other people with Ulcerative Colitis in the future.

About this Study

This study evaluates whether a new medication that blocks the TL1A protein can effectively treat moderate to severe ulcerative colitis when other treatments have not worked adequately.

Study Purpose

This study tests a medication that works through a completely new mechanism - blocking the TL1A protein that plays a key role in gut inflammation - potentially offering a new option for patients who haven't found relief with existing therapies.

Duration

The main part of the study lasts about one year (52 weeks). This includes a 12-week initial treatment phase followed by a 40-week maintenance phase. After that, there's an opportunity to continue in an open-label extension phase.

Location

The study is being conducted at Access Research Institute, located at 11373 Cortez Blvd Building C, Suite 200, Brooksville, FL 34613.

See If You Qualify

Meet your Doctor!

Dr. Salman Muddassir, MD, FACP

Dr. Salman currently serves as program director for the Internal Medicine Residency Program at Oak Hill Hospital. He received his medical degree from Quaid-e-Azam University and his pre-medical training was at Sir Syed College. He then served for 13 years at Seton Hall University Internal Medicine Program at Saint Francis Medical Center in New Jersey where he completed his internal medicine residency and was a chief resident.

Board Certified

Internal Medicine

Top Physician

Consumer Research Council of America 2010, 2011, 2014 & 2015

20+ Years

Clinical Experience

"As a doctor, I see how challenging ulcerative colitis can be. This study is a way for us to explore potential options that may help people feel better and live healthier lives. Every person who joins helps us move one step closer to better care in the future."

Schedule Your Free Evaluation

Study Benefits

Participating in our study offers several potential advantages for patients with ulcerative colitis.

Access to Advanced Treatment

Participants may receive access to innovative treatments that are not widely available in standard clinical practice.

Expert Care Team

Our specialized team of doctors, nurses, and specialists provide comprehensive care throughout the study.

No CostTreatment

Study-related treatments, evaluations, and follow-up visits are provided at no cost to eligible participants.

Medical Advancement

By participating, you help advance medical knowledge and potentially improve future treatments for this condition.

See If You Qualify

How to Enroll

Ready to join our clinical study? It's simple. Just follow these easy steps.

Initial Consultation

Schedule your first chat with our friendly team. We'll talk about your health and see if this study is a good fit for you.

We'll go over your health background, current care, and understand your condition better.

We'll walk you through everything about the study – the potential benefits and risks, what to expect, and answer all your questions.

Screening Process

Next, we'll do a quick check-up to make sure the study is right for your specific needs.

Informed Consent

If you feel ready to move forward, you'll review and sign the informed consent form.

This important paper explains everything: what happens in the study, the timeline, and your rights as a participant.

You'll get a personalized treatment plan made just for you, along with a clear schedule for your participation.

Begin Treatment

Embark on your study journey and begin your first treatment session!

Frequently Asked Questions

Find answers to common questions about our clinical research study.

A clinical trial is a research study that evaluates new medical treatments, interventions, or devices to determine if they're safe and effective for humans. These studies follow strict scientific standards and regulatory guidelines to protect participants' safety and rights. By participating in our clinical trial, you're helping to advance medical knowledge and potentially improve future treatments for this disease.

Have more questions about the study?

Call Our Friendly Team

Schedule Your Free Evaluation

Find out if your a good fit for the study. Our team will contact you within 24 hours.

Doctor and patient discussing treatment options

Why Schedule Today?

Limited Enrollment Period

We can only accept a limited number of participants for this study.

No-Cost Evaluation

Your consultation and all study-related care is provided at no cost to you.

No Obligation

The consultation is informational only - you decide if the study is right for you.

Check Your Eligibility Now

Complete this quick form to see if you qualify

Have you been diagnosed with ulcerative colitis and are actively experiencing symptoms?

Your information is secure and will never be shared with third parties

Come Visit Us

Clinic Location

Address

11373 Cortez Blvd Building C, Suite 200

Brooksville, FL 34613

Hours

Monday-Friday: 9am-5pm

Additional Info

Free parking available

Wheelchair accessible

Get Directions

Call Now